Phibro Animal Health Sees FY2026 Adj EPS $2.52-$2.70 vs $2.03 Est; Sees Sales $1.430B-$1.480B vs $1.278B Est
Benzinga Newsdesk 1 year ago
NewsGuidance
Phibro Animal Health (NASDAQ:PAHC) is looking for FY2026 Adj EPS of $2.52-$2.70 vs $2.03 analyst estimate. sees sales of $1.430 billion-$1.480 billion vs $1.278 billion analyst estimate.
Phibro Animal Health (NASDAQ:PAHC) is looking for FY2026 Adj EPS of $2.52-$2.70 vs $2.03 analyst estimate. sees sales of $1.430 billion-$1.480 billion vs $1.278 billion analyst estimate.